Checkpoint Therapeutics I...

NASDAQ: CKPT · Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM

Checkpoint Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
33.04M 6.6M 4.7M 4.95M 11.24M 4.93M 1.77M 7.42M 4.85M 12.07M 20.48M 30.89M 41.48M 54.73M 60.2M 65.12M 60.03M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a 41K n/a n/a 31K 31K 35K 73K 48K 18K 52K 17K 29K 155K 68K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
1.12M 867K 476K 678K 734K 450K 415K 886K 1.01M 1.15M n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
34.16M 7.47M 5.18M 5.67M 11.97M 5.38M 2.22M 8.34M 5.9M 13.29M 21.62M 32.08M 42.91M 55.73M 60.97M 66.12M 61.43M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
34.16M 7.47M 5.18M 5.67M 11.97M 5.38M 2.22M 8.34M 5.9M 13.29M 21.62M 32.08M 42.91M 55.73M 60.97M 66.12M 61.43M
Account Payables
n/a 6.09M 7.89M 10.84M 11.92M 6.57M 7.96M 8.06M 14.14M 11.54M 13.05M 12.58M 9.86M 16.14M 7.81M 5.08M 3.53M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
17.87M 2.08M 1.23M 9.81M 708K 1.33M 2.35M 6.7M 3.92M 11.45M 369K 349K 297K 233K 282K 201K 374K
Total Current Liabilities
17.87M 20.1M 17.77M 21.42M 22.23M 18.43M 21.26M 31.61M 28.07M 32.77M 22.95M 24.62M 22.69M 25.98M 13M 9.25M 7.25M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a 20.3M n/a n/a 10.87M n/a n/a n/a n/a
Total Liabilities
17.87M 20.1M 17.77M 21.42M 22.23M 18.43M 21.26M 31.61M 28.07M 32.77M 22.95M 24.62M 22.69M 25.98M 13M 9.25M 7.25M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
268K 5K 5K 4K 4K 3K 2K 2K 1K 1K 10K 9K 9K 1K 9K 9K 8K
Retained Earnings
-381.79M -370.57M -341.67M -331.95M -325.28M -314.33M -295.2M -289.48M -272.96M -262.49M -241.46M -230.85M -216.71M -199.86M -170.11M -158.84M -149.7M
Comprehensive Income
n/a n/a n/a n/a 3.42M 3.42M n/a n/a n/a 1.89M n/a n/a n/a 6.6M n/a n/a n/a
Shareholders Equity
16.3M -12.63M -12.59M -15.75M -10.25M -13.05M -19.04M -23.27M -22.18M -19.48M -1.33M 7.46M 20.22M 29.75M 47.97M 56.87M 54.17M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a